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Continuous arteriovenous hemofiltration: An in vitro simulation and
mathematical model. In vitro and mathematical models of continuous
arteriovenous hemofiltration (CAVH) have been developed. Human
erythrocytes resuspended in normal saline containing 5% bovine albu-
min were used to perfuse the circuit from a gravity driven pressure
source. Membrane hydraulic permeability was observed to decline from
31.2 x l0 11.9 x io cm/(min mm Hg) before use to 12.3 x io
3.3 X lO (mean SD) after use. This fall occurred during the first
one to two hours whether perfused with blood or 5% albumin alone.
Pressure-flow relationships of each circuit component, measured with
40% sucrose as a calibration medium, conformed to Poiseuille's equa-
tion. Use of high resistance blood access on the venous end of the
circuit resulted in a low blood flow rate and high filtration fraction. The
same access, when placed on the arterial end, produced both low blood
flow rate and low filtration fraction. These results were a consequence
of pressure distribution within the circuit as demonstrated by measure-
ments of perfusion, prefilter, and postfilter pressures. The importance
of negative pressure applied to the filter chamber in order to maintain
favorable Starling forces, when the system was operated with a small
bore arterial access, was demonstrated by similar methods. Enhance-
ment of urea clearance by predilution was verified. Model simulations
suggest that predilution will be of less benefit or even detrimental for
other solutes which fail to distribute across the erythrocyte membrane.
Comparison of results with predictions of a mathematical model dem-
onstrated good agreement, but with some tendency to overestimate
filtrate production. The latter was attributed to neglect of concentration
polarization of plasma proteins in model development.
Continuous arteriovenous hemofiltration (CAVH) is often
performed in critically ill patients who are too hemodynamically
unstable for pump driven ultrafiltration or hemodialysis 11—4].
In vivo study of CAVH may be hampered by variation in mean
arterial pressure (MAP) or filter characteristics which may
produce greater changes in filtrate output than perturbations
introduced by an investigator. With these limitations in mind,
we have constructed an in vitro apparatus capable of perfusing
the CAVH circuit at constant pressure. Systematic study was
then undertaken in order to determine optimum configuration
for enhancement of solute and volume removal. Additionally,
measurements of individual component characteristics were
performed in order to permit comparison of experimental
findings with the predictions of a mathematical model. Ques-
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tions regarding the relative resistances of individual compo-
nents, time dependent changes in filter permeability, access
configuration, predilution versus postdilution, and filtration
equilibrium have been investigated.
Methods
Perfusion apparatus
A schematic drawing of the device used to perfuse the CAVH
circuit is depicted in Figure 1. Blood, stirred and maintained at
constant temperature, was pumped from reservoir 1, Ri, to a
second reservoir, R2, maintained at an elevation, H. A second
pump returned this blood to the lower reservoir, thereby
maintaining a constant level in R2 and continually recycling its
blood. A third reservoir, R3, into which the arterial access of
the CAVH circuit was placed, was perfused with blood from
R2. Pressure in R3, the arterial perfusion pressure, was set by
adjusting the height, H. R3 was also stirred continuously to
prevent settling of red blood cells (RBC's) between measure-
ments. Pressure was monitored in R3, and at prefilter and
postfilter locations. R3, pressure ports, hemofilter, and venous
access were maintained at the same level, equivalent to speci-
fying a central venous pressure (CVP) of zero. Dilution fluid
was added either prefilter, or postfilter, at locations shown in
Figure 1. In practice, dilution fluid was recycled back to its
reservoir at a preset rate, Qd, in order that valve 2, V2, could be
turned on at the same time flow through the system was
initiated (by unclamping tubing upstream of R3). The height of
the ultrafiltrate column, HI, was maintained at 40.5 cm in order
to provide a negative pressure of 30 mm Hg inside the filter
chamber. Standard Amicon® CAVH tubing (length 91.4 cm,
internal diameter 0.317 cm) and Diafilter®-20 (D-20, 5000 hollow
fibers of 12.5 cm length and 0.02 cm internal diameter,
polysulfone membrane) hemofilters were used throughout these
experiments. A similar in vitro device has been used by
Fecondini and Ronco et alto study CAVH [5].
Blood
A perfusate with the rheologic and oncotic properties of
blood was obtained by resuspending units of packed RBC's in
5% bovine serum albumin dissolved in normal (0.9%) saline.
Units of packed cells that were obtained from Stanford Univer-
sity Hospital blood bank had been rejected for patient use
686 Pa/lone and Petersen: CA VH: In vitro and mathematical simulations
Fig. 1. Apparatus used to perfuse the CAVH circuit. Blood was provided at constant pressure to reservoir 3 (R3), by adjusting height, H, of
reservoir 2 (R2). Using valve 1 (V 1), pressure was monitored in R3, prefilter. or postfilter locations. Lengths in centimeters were L 91.4, L1
15.7, L2 21, L3 = 34, L = 63. Height, HI, was 40.5cm except where otherwise specified. Height, H, was varied in order to achieve the desired
perfusion pressure in R3 during operation.
because they were of insufficient quantity, outdated, or overir-
radiated. Units were of mixed type and used within five weeks
of donation. The hematocrit of blood prior to resuspension was
60 to 90%, thus the final protein composition of the plasma was
almost entirely albumin. The final blood was filtered through
several layers of gauze to remove any particulate material.
We determined that the hematocrit of the system remained
constant for 10 to 14 hours of continuous operation provided
that the temperature of reservoir I (Fig. 1) was maintained at
33°C instead of 37°C. Temperature of blood perfusing the
CAVH circuit was 30°C under these conditions and was the
value used as input for model simulations of in vitro data.
Hematocrits were measured by capillary centrifugation and
protein concentration by the method of Lowry, Rosenbrough
and Farr 61. Where required, urea was added at a concentra-
tion of 50 mg/dl. Measurements of urea concentration in plasma
or filtrate were performed on a BUN analyzer (Beckman
Instruments, Palo Alto, California, USA). By recombining
blood and filtrate at the end of collection periods, the hemato-
crit of the system was maintained at a constant level and blood
continuously reused.
Clearance measurements
Measurements of filtrate production and blood flow rate were
performed by timed collection of filtrate and venous outflow.
Perfusion pressure was set during flow, prior to initiation of a
collection period. After adjusting the height of R2 (Fig. 1), flow
was stopped and the collection period initiated by simulta-
neously unclamping tubing upstream of R3 and redirecting
dilution fluid (when required) using valve 2. Collection periods
were one to six minutes depending upon the rate of filtrate
production. Care was taken to perfuse all of the fibers by
eliminating air pockets. Transients were much less than collec-
tion times, and pressures appeared to stabilize immediately
upon intitiation of flow.
Component resistance
Poiseuille's law states, for a simple cylinder,
LW = R11zQ (1)
R2
Arterial
R3,
port Venous access
Perfusion pressure port
Peristaltic pump
Postfilter pressure port
Hi
Filtrate column
Ri
Stirrer Heater
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8L,R1 =
—i
irr1
where R is the quantity that we will define as the resistance of
the ith component, r, is its internal radius, L, its length, Q the
flow rate through the device, and , the viscosity of the
perfusate. Resistance, so defined, is a function only of the
geometry of the device, and has units of I/cm3. The hollow
fibers of the hemofilter represent many such resistances lying in
parallel. The hemofilter may be expected to behave according
to equation I with its resistance, Rf, defined in terms of the
number of hollow fibers, N, their internal radius, rf, and length,
Lf, by:
8L1Rf=
N lrrf
In order to measure CAVH circuit component resistances, a
40% sucrose solution at room temperature (23°C) was used as
perfusate. This medium permitted all resistance determinations
for individual components to be performed in the laminar flow
range. Flow rates across the components at various perfusion
pressures were measured by timed collection. Individual resis-
tances were calculated by dividing the pressure drop across the
component by the product of flow rate and viscosity of sucrose.
The latter was obtained by interpolation of published tables
(5.61 centipoise, or 7.01 >< 1O7 mm Hg mm at 23°C) [71. All
filter resistances were measured after use in order to avoid
fouling of the membrane. In order to prevent transmembrane
shifts of the calibration medium, the filtrate side of the filter
chambers was loaded with the same sucrose solution and
occluded prior to performing these measurements.
Filter permeability
The hydraulic permeability of each filter was determined by
perfusing with normal saline, clamping the venous outflow, and
measuring prefilter pressure, postfilter pressure, and filtrate
production rate. The axial pressure drop across the filter was
less than 3 mm Hg under these conditions. The transmembrane
pressure gradient (TMPG) was calculated according to,
1p0 + p1 1
TMPG= 2
and the hydraulic permeability, L0, by,
Qf
=
TMPG(S)
where P0 and P are pre- and postfilter pressures, respectively,
Pf the negative pressure exerted by the ultrafiltrate column in
mm Hg (0.74 >< column height in centimeters), Q the ultrafil-
trate production rate mI/mm, and S the manufacturer's specifi-
cation of membrane surface area for the hemofilter (2500 cm2
for the D-20). Hydraulic permeability measured by this method
was independent of the perfusion pressure, and did not vary if
normal saline or water was used as perfusate. Note that L0
represents the ultrafiltration coefficient per unit of membrane
surface area. As such, the units of L0 used throughout this
report are expressed as cm/(min mm Hg) which is equivalent
(2) to cm3/(cm2 mm mm Hg).
Symbols and units.
Iviathematical model
C, C1, concentration of the th solute (cs, mmol/liter), or
protein (C,,, g/dl)
J, f, fractional volume of distribution of the jth solute
(i), or urea (fLI) within the erythrocyte
H hematocrit of systemic blood expressed as a vol-
ume fraction
transmembrane volume flux (cm/mm)
length of the i11' component (L), or filter (Lf), (cm)
hydraulic permeability (cm/(min mm Hg))
Mass flow of the th solute (mmol/min)
number of hollow fibers lying in parallel within the
hemofilter
P1 pressure (i = a, v, f, o, 1), (mm Hg)
P. membrane Peclet number for the th soluteP radial Peclet number for proteinsQ flow rate (i = c, b. f, dl, d2), (mI/mm)
R ratio of Poiseuille resistance to viscosity (i = aa,
Va, at, vt, fl, (I/cm3)
r internal radius of the i°' component or hollow fi-
bers (rf), (cm)
S total membrane surface area within the hemofilter,
(cm2)
T absolute temperature (°K)
x axial position within the hemofilter (cm)
Greek letters.
rJ local hematocrit within the circuit expressed as a
volume fraction
sieving coefficient of the j'5 solute (), or urea (On)
empirical constant (equation 17)
viscosity (i = w, b, p), (mm Hg mm)
oncotic pressure due to plasma proteins ir,, or
albumin ir (mm Hg)
a empirical factor used in the calculation of blood
viscosity (equation 11)
Subscripts.
(4) aa arterial access
ye venous access
at arterial tubing
Vt venous tubing
a arterial or albumin(5) h blood
c red blood cells
d dilution fluid (dl = predilution, d2 = postdilution)f filter (in the case of Pf, pressure in the filter cham-
ber, outside the hollow fibers), or filtrate
1 postfilter
o prefilter
p plasma or plasma protein
a urea
v venous
n' water
with,
Jr
L1, L1
L1,(3) M
N
UI, O,
IT0, 3T,
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value of the variable on entry into the circuit, the
systemic value
normal value for human blood
General considerations
Development of the model relies upon several assumptions.
The first of these is that the pressure-flow relationships of each
of the CAVH circuit components may be described by Poiseuil-
le's law (equations 1—3). At sufficiently high shear rates, blood
has been shown to behave as a Newtonian fluid [8, 91. There-
fore, provided that flow is laminar (Reynold's number less than
2000), the above equations may be expected to apply.
A second assumption concerns the pressure distribution in
the hemofilter. The approach of this study has been to calculate
this according to Poiseuille's law in differential form,
dP R
= — — P'bQb
dx Lf
Computations based upon equation 6 are possible provided that
the spatial dependence of jt,, is known throughout the hemofil-
ter. Even so, its derivation from the Navier-Stokes equation
requires constant viscosity as a preliminary assumption. Within
the hemofilter, hematocrit and plasma protein concentration
rise. Blood viscosity is dependent upon both of these, so that
use of equation 6 requires justification. This may be based upon
an order-of-magnitude analysis of the Navier-Stokes equations,
which shows that, for conditions of operation in CAVH, those
terms involving spatial derivatives of viscosity may be ne-
glected. Equation 6 is then derived, but with tb a function of
axial location, x.
A third assumption has been that filtrate production by the
hollow fibers may be estimated by Starling's equation,
= L,{(P — Pf) — (7)
where J,, is transmembrane volume flux, L hydraulic perme-
ability, P hydraulic pressure, Pf the external pressure applied to
the filter chamber (generally negative), and ir.,, is intraluminal
oncotic pressure due to plasma proteins. The latter was deter-
mined by the Landis-Pappenheimer equation [10],
= 2.lC + 0.16 C,2 + 0.009 C,3 (8)
In view of the composition of the plasma used in our studies,
Pappenheimer's equation for albumin has been used in place of
that for plasma proteins to specify oncotic pressure, lTa,when in
vitro and mathematical simulations were compared.
lTa = 2.8 Cp + 0.18 Cp2 + 0.012 Cp3 (9)
When hemofiltration is performed with increasing transmem-
brane pressures, the rate of filtration approaches a maximum.
The magnitude of the limiting transmembrane volume flux is
dependent upon the velocity of blood flow within the fibers
(shear rate), and hematocrit [11]. Convective movement of
proteins must be balanced by diffusion back into the bulk
solution. A radial concentration gradient is established and
enventually, at high volume flux, a "gel layer" is formed at the
membrane surface. Further increases in transmembrane pres-
sure increase the gel layer without increasing filtrate formation
[121, This phenomenon is termed concentration polarization.
Filtration rates in CAVH are quite low by comparison to pump
driven systems and the dependence of filtrate production rate
upon the transmembrane pressure gradient remains. At suffi-
ciently low flux, filtrate formation should conform to equations
7 and 8. In agreement with our approach, Lysaght, Schmidt and
Garland found a linear dependence of filtration rate upon
transmembrane pressure [131, and concluded that concentration
polarization of proteins does not dominate membrane behavior
for conditions of operation in CAVH.
It has been assumed that when CAVFI is operated in predilu-
tion mode, urea rapidly equilibrates between RBC and plasma.
The half time for RBC equilibration following a step change in
urea concentration is about 0.2 seconds [14], much less than
circuit transit time. Furthermore, it has been assumed that
dilution fluid and blood are well mixed whether predilution or
postdilution is employed.
(6) The patient has been simulated as two pressure reservoirs,
the first at the MAP, from which blood flows to a second at the
central venous pressure, CVP. The pulsatile nature of blood
flow has been neglected. Results are most comparable to
system configurations employing blood accesses in the central
circulation, such as femoral artery or vein.
Blood rheology
In order to calculate pressures throughout the system, blood
viscosity must be related to local hematocrit, 4, and plasma
protein concentration, Ci,. The following equation, which de-
termines the effect of spherical particles on the viscosity of a
suspension has been described by Einstein [15] and Jeffery [16].
-
1
where a is the shape factor (2.5 for spheres), 4) is the volume
fraction of the spheres, p and j are the viscosity of the
medium with and without the particles, respectively. In order to
account for the behavior of blood, Charm and Kurland [17]
have determined that the following empirical formula describes
the variation of a with hematocrit, 4), and temperature.
I /uo\a = 0.07
ex.[2.49F
+
t—) exp(—l.69) (11)
where T is absolute temperature (°K), and p,,, the viscosity of
plasma, and /Lb, the viscosity of blood, are substituted for and
respectively, in equation 10. An inherent assumption in the
use of this and other model equations, is that blood will behave
as a Newtonian fluid. This is valid provided that shear rates are
sufficiently high. Merrill et al have studied the relationship
between shear stress and shear rate for blood flowing in small
hollow fibers [8, 18]. They demonstrated that a linear relation-
ship (Newtonian behavior) exists for average flow velocities,
U= 4Q/(,i U d3), greater than about 10 sec l, where Q is flow
rate, and d is tube diameter. If we consider a worse case blood
flow rate of 25 ml/min through the CAVH circuit, the minimum
value of U will occur within the hollow fibers and has a value of
about 800 sec* Newtonian behavior has also been demon-
strated up to shear rates several orders of magnitude higher
Superscripts.
(10)
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than that which occurs with CAVH [191, and is therefore
anticipated in all regions of the circuit.
The problem that remains is to estimate the viscosity of
plasma. Although literature exists regarding the correlation of
plasma viscosity with varying protein composition, that is,
albumin, fibrinogen, globulins, a study which relates viscosity
to total protein concentration could not be found. We have
chosen the simplest approximation, that of a linear interpolation
between a normal plasma viscosity, (1.54 x l0 mm
Hg mm), at normal plasma protein concentration, C' (7 gIdl),
and the viscosity of water at 37°C, (0.864 X l0 mm
Hg mm) [201. This is provided by,
Cp
= + (' — ) --
p
We recognize that many factors other than those described
above affect the viscosity of blood, and that equations 10, II,
and 12 provide only an approximation. These equations may fail
to describe circuit behavior when macroglobulinemia, a hyper-
viscosity syndrome, hyperlipidemia, or severe hypopro-
teinemia exists.
Application of Poiseuilles equation to the hemofilter also
neglects the radial gradients in viscosity and hematocrit which
might be induced by transmembrane volume flux. Again, taking
the case of a circuit with blood flow of only 25 mI/mm, and a
filtrate production, Q,of 10 mI/mm distributed over a 2500 cm2
surface area, S, the transmembrane volume flux, J,, will be of
order Qf/S, or 4 x l0- cm/mm. The average axial velocity of
fluid in the same hollow fibers (200 micron diameter) is 16
cm/mm, which exceeds J by greater than three orders of
magnitude. A minimal effect on the parabolic velocity profile,
pressure distribution [211, or radial distribution of RBC's is
expected.
Fahraeus and Lindqvist demonstrated that the apparent
viscosity of blood, when flowing through capillary tubes less
than 300 micron diameter, is less than that observed when flow
is through larger conduits [22]. For the 200 micron fibers
employed in hemofilters, the apparent viscosity is 90 to 95% of
the value measured when the tube is of large radius (the
Fahraeus-Lindqvist effect [231). Because this correction is
small, the Fahraeus-Lindqvist effect has been neglected by our
derivation. The "tube" hematocrit of blood flowing through
small capillaries has been shown to be less than the "feed"
hematocrit of the upstream reservoir (the Fahraeus effect [241).
For hollow fibers of 200 micron diameter, however, tube
hematocrit is expected to be 95% of the feed hematocrit [23,
25]. For this reason, the Fahraeus effect has also been ne-
glected.
S
— (Ma) = (16)
Ji = ej
— (1 —
exp(—Pe)J
proteins will have negligible effect on RBC volume. In an
otherwise isosmotic system, cell flow rate, Q. is constant,
Q, = H (14)
and,
(15)Q + Q
where H and tb are the hematocrit and flow rate of blood
entering the arterial access, and is the local hematocrit within
the hemofilter.
Conservation of the )th solute yields,
(12) d
dx
where, M is the mass flow rate of the solute,
M = C{(l — 'PC)Q + fQ} (17)
J, the transmembrane flux ofthejth solute, is derived from the
Patlak equation [26], subject to the assumption that Cf =
which yields,
(18)
where, Pe is the membrane Peclet number for the jth solute,
(19)
C, and C1f are the concentration of the th solute (unbound) in
plasma water and filtrate, respectively, b is sieving coefficient
(one minus the true membrane reflection coefficient) for the th
solute, P the diffusive permeability of the membrane for the th
solute, f the fractional volume of distribution within the eryth-
rocyte, and the factor (1 - /iC) is used in the manner of Colton
et al [11] to account for the volume fraction of plasma inacces-
sible to dissolved solute due to the presence of proteins (i/i =
0.0107).
Equations 16 through 19 assume that the th solute equili-
brates across the RBC membrane much more rapidly than
circuit transit times. While this is reasonable for urea, this
assumption will not hold for many other solutes. It is, however,
possible to consider the limiting case of solutes that either do
not distribute into the RBC, or undergo no equilibration. Both
of these cases can be addressed by setting f 0. This issue is
explored in a later section of this report. For unbound solutes
whose sieving coefficient is unity, in the absence of predilution,
concentrations throughout the circuit will not vary and a
Conservation equations gradient across the RBC membrane will not be produced. For
Subject to the above assumptions, conservation of volume such solutes, such as creatinine, the value assigned to f has no
for the plasma compartment, within the filter, takes the form, effect on the solution and the model remains applicable in the
absence of predilution.
'C" = —J - '13) In this development, attention is restricted to solutes whichdx "i" " Lf are not bound to carriers in the plasma, so that sieving coeffi-
cients less than unity imply membrane restriction rather than
where Q,, is plasma flow rate, and S the total membrane surface the transmembrane flux of an unbound fraction. Macromolec-
area within the hemofilter. It is easily shown that the small ular carriers in the plasma would be concentrated during
variation in plasma oncotic pressure due to concentration of hemofilter transit. For this reason, a model describing solutes
Jvej
=
Pi
690 Pa/lone and Petersen: CAVH: In vitro and mathematical simulations
which are partially bound would necessarily address the kinet-
ics of that binding.
Finally, conservation of plasma protein yields, for the local
protein concentration, Ci,,
-
— H)p-
where , refers to systemic plasma protein concentration.
Pressures
Pressure upstream of the arterial access is a (equal to the
MAP). Prefilter pressure, P0, was calculated according to,
P0 = Pa — (Rat + Raa)Qbpb
where Raa and Rat are the ratio of Poiseuille resistance to
perfusate viscosity as defined by equations 2 and 3 and applied
to the arterial access and arterial tubing, respectively. Hema-
tocrit and plasma protein concentrations used to compute pb in
equation 21 were H and . Note that this specified addition of
predilution fluid at the junction of the filter and arterial tubing.
The pressure within the hemofilter was computed according to
the appropriate form of equation 6,
(P) =
—R(Q + Q)dx Lf
where 4) and C, used to calculate b were obtained from
equations 15 and 20, The postcircuit pressure, Ps,, was deter-
mined by,
Pv = Pi — (Rva + R)(Q1 + Qd2 + Q)pi,
where P1 is the postfilter pressure obtained upon integration of
equation 22 from x = 0 to x = Lf, plasma flow rate at x =
L, Qd2 the rate of flow of any postdilution fluid (added at the
junction of the filter and venous tubing), and Rva are the
ratio of Poiseuille resistance to viscosity for the venous tubing
and venous blood access, respectively. In equation 23, /Lb was
calculated using the hematocrit, 4,
Q
Q + Q + Q
and plasma protein concentration, C,1,
-
(1 - H)bC
Cl,!— pl + d2
In all cases, the subscript "o" refers to values of variables at x
0 (filter inlet), and "1" to values at x = Lf (filter outlet).
Boundaty conditions
In order to integrate equations 13, 16, and 22, prefilter values
of the variables P, Ci,, Q,, and C were required. These were
obtained from equation 21 and the following.
Q0 = (1 — H)Qb + Qdl
(1 — H)CQb
Cpo=
(22)
(23)
(28)Qdt + Qb
and
(20) c0 = (1
— I')(l — H) + (29)(1 —
'I'C0){(1 — H)Qb + Qdl} + QC
Qdt is the rate of addition of any predilution fluid, and refers
to the concentration of the th solute in systemic plasma water,
Solute clearances
Clearance of the Jt solute, C1, was calculated as the differ-
(21) ence between its mass flow rate upstream and downstream ofthe filter divided by C.
Cl3 = {C30[(1 — 'I'C0)Q0 + fQCJ —
C3[(l — I' C1)Q1 + f3Q]} (30)
If predilution is not performed, the sieving coefficient of the
solute is unity, and the small correction I' is neglected, then
CC3 = C30 = C31, and equation 30 reduces to,
Cl3 = Q0 — Qi = Qf (31)
where, Q is filtrate formation rate.
Computation
The blood flow entering the circuit, Qb was determined by
iterative solution of the governing equations. The condition met
was that the postcircuit pressure, Ps,, must be equal to the
specified CVP. The equations were then solved with successive
adjustments of Qb until,
I(CVP — PV)/CVPI < i0 CVP> 1 mm Hg (32)
or,
ICYP — P < l0- 0 < CVP < 1 mm Hg (33)
Equations were numerically integrated by the method of Gear
(24) [271 with double precision arithmetic specification (16 signifi-
cant figures).
Results
(25) Component resistances
Typical results, when individual components of the CAVH
circuit were perfused with the sucrose solution at various
pressures are depicted in Figure 2. Clearly, each component
behaves as a simple linear resistor. The inverse of slopes in
Figure 2 divided by the viscosity of 40% sucrose yields the
resistance. Measured resistances are summarized in Table 1.
Also shown are the theoretical values calculated using equa-
tions 2 or 3. Agreement is reasonable, suggesting the important
(26) fact that these parameters, essential for modeling other sys-
tems, can be estimated from component geometry. Model
simulations in this report make use of the mean values for blood
(27) accesses and tubing in Table 1. Due to the variability of filter
resistance and permeability, however, individually measured
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values were employed. These are specified as required in the
remainder of the text.
Filter hydraulic permeability
Filter permeability changed markedly during use. Hydraulic
permeabilities of seven filters, measured prior to and at the end
of experimentation, are shown in Figure 3A (perfusion time 6 to
14 hours). Variability was high, and values have a negative
correlation with measured resistances (data not shown). Mean
hydraulic permeability measured before experimentation was
31.2 x l0— 11.9 x l0— cm/(min mm Hg), and after, 12.3 x
i0 3.3 x l0 (mean SD). Decline in filtrate output was
consistently observed during the first one to two hours of use.
That this decline occurs early and is a consequence of interac-
tion of protein with the membrane surface is demonstrated by
the result depicted in Figure 3B. Five percent albumin in normal
saline, without RBC's, was used to perfuse a filter for several
hours at 40 mm Hg while ultrafiltrate formed freely. At hourly
intervals the filter hydraulic permeability was measured. As
shown, L fell markedly within the first hour, but stabilized
thereafter. Prolonged perfusion with normal saline or water
produced no such change.
Table 1. Component resistances
-
(x iO,
Resistance 1/cm3)
Component N measured Calculateda
Blood access
Vygon® 3 1.52 0.06 0.894
Medium 3 7.63 0.39 10.4
Small 3 29.1 1.8 34.6
AT 3 5.23 0.08 3.69
VT 3 4.46 0.06 3.69
Filter 6 8.74 5.2 6.37
Parameter values and sensitivity analysis
Having measured the necessary parameters, it is possible to
select a set of "base case" values for model exploration. These
400
300
E 200
a
100
0
Fig. 2. Pressure-flow relationships for individual CA VII components
when perfused with a solution of 40% sucrose. Abbreviations are: V.
vygon catheter; V.T., venous tubing; A.T., arterial tubing; F, filter; M,
medium bore blood access; S, small bore blood access.
Pressure loss, mm Hg
Results are mean 5D. Abbreviations are: AT, arterial tubing; VT,
venous tubing.
Calculated from equations 2 or 3
A
60-
50
E
Mean Before After Mean
B
60
50
E
E
. 30
20
10
0 1 2 3
Time, hours
Fig. 3. A. Hydraulic permeabilities of each of seven hemofilters before
and after experimentation. B. Time course of the decline in permeabil-
ity when a single filter was perfused with 5% albumin. Numbers on the
ordinate are to be multiplied by l0.
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v-v v-s
BC Perturbed
Pmtr value value
Pa
P
P1
Ra
60
mm Hg
10
mm Hg
—30
mm Hg
6.75 >< l0
I/cm3
45
75
7.5
12.5
—37.5
—22.5
5.06 x l0
8.44 X lO
0.70
1.30
1.05
0.95
1.00
1.01
1.09
0.93
0.80
1.19
0.98
1.02
1.17
0.83
1.05
0.95
0.77
1.22
1.07
0.93
0.95
1.05
1.03
0.97
0.72
1.22
1.03
1.00
1.04
0.93
1.03
0.97
R 5.98 x 10
1/cm3
4.49 X iO
7.48 x iø
1.08
0.93
0.96
1.03
—
—
—
—
R. 33.6 X iO
1/cm3
25.2 x i05
41.9 x i05
—
—
—
—
1.29
0.81
1.09
0.88
Rf 8.74 x iO
1/cm3
6.56 x l0
10.9 x 10
1.11
0.91
1.01
0.99
1.05
0.96
1.04
0.96
S 2500
cm2
1875
3125
1.01
1.00
0.77
1.22
1.07
0.96
0.88
1.03
L 12.3 x iO
cm/(min.mm Hg)
9.23 x iO
15.4 x iO
1.01
1.00
0.77
1.22
1.07
0.96
0.88
1.03
H 0.3 0.23
0.37
1.15
0.85
1.02
0.98
1.27
0.70
1.15
0.70
f, 0.86 0.72
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00
1.00t 6
g/dl
4.5
7.5
1.12
0.91
1.20
0.77
1.01
0.96
1.24
0.76
T 37°C 27.8
46.8
0.95
1.05
1.00
1.00
0.92
1.07
0.95
1.04
Abbreviations are: Pmtr, parameter; Ra, R +
are shown in Table 2. We have chosen systemic pressures,
hematocrit, and plasma protein concentration to be consistent
with the treatment of a critically ill patient. The base case
circuit is demonstrated as one of two access configurations,
which employ the Vygon catheter as the arterial access along
with either a Vygon catheter (V-V configuration) or small
access (V-S) on the venous end. These configurations are used
extensively for the model simulations in this report. The
hemofilter is the Diafilter-20. Values for prefilter resistance, Ra,
or postfilter resistance, R, are taken as the sum of the resis-
tances of the pre or postfilter access and tubing as specified in
Table 1. L is chosen as the postequilibration value from Figure
3A. For reference, sensitivity of the model to changes in the
various parameters is also shown in Table 2 as the response of
blood flow and filtrate production rate to 25% increases or
decreases of parameter values (perturbed values) for either
access configuration. The latter is expressed as the ratio of the
blood or filtrate flow rate to its base case value.
Access configuration
Three accesses were used in these experiments. The smallest
was a steel needle of 0.95 mm internal diameter (approximately
18 guage) and 8.5 cm length, a medium size steel needle of 1.3
mm internal diameter (approximately 15 guage) and 7.3 cm
length, and the largest a Vygon® plastic catheter of 3 mm
internal diameter and 14 cm length in series with a plastic
connector of 3.5 mm diameter and 7 cm length. These were
chosen to span the range of access resistances which might be
mi/rn inOrder Configuration Hct.
I V-V 26.9 10.8 87.0 9.74
2 V-S 26.5 10.5 87.5 9.75
3 S-V 26.5 10.0 85.9 9.31
4 V-M 27.3 9.71 85.3 9.05
5 M-V 26.9 9.50 84.5 8.95
used in practice to perform CAVH. Throughout the remainder
of this report they will be referred to as the small (S), medium
(M), and Vygon (V) catheters, respectively. Access configura-
tions will be abbreviated as V-S corresponding to a Vygon
catheter on the arterial and small catheter on the venous end.
Configurations tested were V-V. V-M, V-S, M-V, and S-V.
Accesses were sequentially placed on the venous and arterial
ends of the CAVH circuit opposite the Vygon catheter in the
order shown in Table 3. Measurements of blood flow and filtrate
formation were obtained as perfusion pressure was increased
from 50 to 100 mm Hg. In order to control and determine
variation in filter properties, the system was perfused (as in all
experiments) for one hour prior to testing. Before and after the
period corresponding to a given access configuration, the filter
was flushed until clear with normal saline at a perfusion
pressure of 67 mm Hg, and the hydraulic permeability mea-
sured. Additionally, the same data point corresponding to the
V-V configuration at 70 mm Hg was repeated. Table 3 summa-
rizes the results of these controls. The hematocrit of the system
was stable, but the permeability decreased somewhat.
Blood flow rate entering the arterial access. b' was deter-
mined as the sum of filtrate formation and venous outflow. This
quantity is shown as a function of perfusion pressure, Pa, along
with model predictions in Figure 4. A similar plot of filtrate
production is shown in Figure 5. Model predictions were
calculated on the basis of a hematocrit of 27%, plasma protein
concentration of 6.1 g/dl, filter resistance of 18.1 x l0 1/cm3
and the permeabilities shown in Table 3. (Of the filters used, the
one used in this experiment had the highest resistance and one
of the lowest permeabilities.) Agreement of measured and
predicted blood flow rates was reasonable for all configurations.
Filtrate production, Q, was close to predictions except for the
V-S configuration where overestimation occurred. In this con-
figuration, the ratio of transmembrane volume flux to axial
velocity of blood was highest. It is probable that the lower wall
shear rates permitted greater polarization of proteins 1111. Even
in this configuration, the trend in model prediction of Q was
qualitatively correct.
The driving forces responsible for the pattern of filtrate
production in Figure 5 are clarified upon examination of Figure
6. The fraction of the arteriovenous pressure gradient lost
across prefilter, filter, and postfilter portions of the circuit is
shown for each configuration. Consistent with model predic-
tion, these fractional losses were found to be independent of the
perfusion pressure. As the resistance of the arterial access
increased, more pressure was lost upstream of the filter,
thereby decreasing driving forces available to promote ultrafil-
tration. Conversely, as the resistance of the venous access was
increased, a larger fraction of the gradient was dissipated
Table 2. Base case values and sensitivity analysis Table 3. System stability
Lp(x l0)
cm/(min mm Hg)
Qh Qr
Rat; R, Rva + R;
BC, base case. Perturbed parameter values are +/— 25% of their base
case value. Table entries are the ratio of the perturbed value, Q to the
base case value, Q*
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10074
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MV
50
Pa, mm Hg
downstream of the filter resulting in greater pressure to promote
filtrate production. Through this mechanism, large venous
resistances markedly increase filtration fraction and decrease
blood flow rate.
Filtration equilibrium
As has been demonstrated, when CAVH is operated with
small bore arterial accesses, prefilter pressure may be quite
low. Under these conditions, filtrate formation depends largely
upon negative pressure applied by the ultrafiltrate column. In
order to investigate this, the column height was varied from
zero to 70 cm while the system was operated in the V-V or S-V
configuration at a perfusion pressure of 60 mm Hg. Plasma
protein concentration was 4.4 g/dl and hematocrit 27.3%. Filter
resistance and hydraulic permeability were 6.5 XIO 1/cm3 and
14 x l0— cm/(min mm Hg), respectively. Measured and
predicted filtrate flow rate is shown in Figure 7. Filtrate output
increased linearly in both configurations. In each case, agree-
ment with model prediction was best when transmembrane flux
was lowest. Again, this is consistent with deviation from simple
Starling's behavior due to radial polarization of plasma pro-
teins. In the V-V configuration, filtration continued even at a
column height of zero. When a high resistance arterial access
was used, the dependence on negative pressure outside the
membrane was clear, filtrate no longer was formed when
column height was less than about 7 cm. In fact, filtrate was
observed to flow toward the filter indicating reabsorption into
the blood. Prefilter and postfilter pressures were 40 and 17 mm
Hg in the V-V configuration, and 14 and 3 mm Hg in the S-V.
Model predictions were 39 and 19, and 16 and 8 mm Hg,
Fig. 4. Blood flow rate, b' entering the arterial
access as a function of perfusion pressure, P,
for various access configurations. Solid lines are
model simulations, while dashed lines are best fit
linear regressions for data points.
Fig. 5. Filtrate formation rate, Qç' as a function of
perfusion pressure for various access configurations.
Solid lines are model simulations, while the dashed lines
are best fit linear regressions for data points.
respectively. Less than 2 mm Hg variation in these pressures
was observed or predicted with changes in column height. For
the S-V configuration, at 7 cm column height, Starling forces at
the beginning of the filter favored filtration by 3 to 4 mm Hg
(using equation 9 to calculate oncotic pressure) while at the end
of the filter, reabsorption was favored. Because of the viscous
nature of blood flow, hydraulic pressure may fall below plasma
oncotic pressure, promoting filtrate reabsorption along part of
the length of the hollow fibers. In this sense, filtration equilib-
rium is a misnomer. Only in ultrafiltering systems with negligi-
ble axial pressure drop can this phenomenon persist for the
length of hollow fibers. Also apparent is that application of
sufficient negative pressure within the filter chamber easily
alters unfavorable Starling forces.
Predilution versus postdilution
Replacement of filtrate can be performed upstream of the
filter (predilution), downstream of the filter (postdilution), or
through a peripheral vein (no dilution). Authors have suggested
that clearances are enhanced when predilution mode is em-
ployed in either hemodiafiltration or CAVH [28, 29]. Decrease
in solute concentration in the filtrate will tend to diminish solute
clearance, while lower oncotic pressure and enhanced filtrate
production will tend to increase solute clearance. A priori, one
cannot be sure that the latter effect will dominate. In order to
investigate this question, we have used the apparatus in both
predilution and postdilution modes using the V-V configuration
at a perfusion pressure of 60mm Hg. Dilution fluid was supplied
at a rate of 10 ml/min at a location 57.4cm upstream of the filter.
In order that a fall in filter permeability not enhance any
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Access configuration
Fig. 6. Fraction of the arleriole000s pre.is!lre gradient lost acl'o55
prefilter (•), filter (1), and postfilrer (r;(I)portions of' the CA VH
circuit. Bar heights are calculated by dividing the observed pressure
drop by the total arteriovenous pressure gradient. Groupings corre-
spond to individual access configurations. Top panel: Model estimates.
These show no variation with perfusion pressure. Bottom panel:
Measurements. Error bars refer to the standard deviation of the six
measurements depicted in Figures 4 and 5.
apparent benefit from predilution, this was the last mode tested.
In order to obtain accurate filtrate urea concentrations, 200 ml
of filtrate was allowed to form in each mode prior to measure-
ment. The hematocrit of the system was stable at 30.5%, and
plasma protein concentration was 6.1 g!dl. Mean filter perme-
ability was 17.8 x l0 cm/(min mm Hg), varying by less than
2% before and after experimentation. Filter resistance was 9.07
x I0 I/cm3. Urea clearance, Cli,, was calculated according to,
=
Cb
where Cf and Ch are the filtrate and perfusate urea concentra-
tions, respectively. Results are shown in Table 4 along with
model predictions. Data shown are the mean of three determi-
nations. In agreement with other investigators and model pre-
dictions, urea clearance was enhanced by predilution. Prefilter
and postfilter pressures were 40 and 19 mm Hg respectively,
while predictions were 42 and 17. Initial blood flow, Qh, of 92
mi/mm was measured, while the model predicted 115 mI/mm.
Predictions and measurements of pressures and blood flows did
not change with dilution mode. Recently, Golper et al, using a
pusatile pump, investigated the effect of predilution fluid infu-
sion on circuit pressures. They also found little effect on
hemodynamics with predilution rates less than 500 mI/hour [301.
Model predictions of filtrate formation and urea clearance
with predilution are shown in Figure 8. Using the base case
parameters for different access configurations, predilution rate,
Table 4. The effect of dilution mode on urea clearance
.Dilution
mode
Urea clearance inl/imn
-
Measured Calculated
None
Post
Pre"
11.02 0.11 11.87
11.06 0.37 11.82
11.74 0.2l 13.19
Qd, was increased from zero to 10 mI/mm. The top curve in
each pair represents filtration rate (solid line), and the lower
curve, urea clearance (broken line). The model predicted that
filtrate formation rate, blood flow rate, and therefore urea
clearance in postdilution do not vary significantly from that
when Qi = 0 (no dilution). A benefit from predilution over
postdilution or no dilution was predicted for all configurations,
but was greatest when a high resistance access was placed on
either end of the circuit. In such cases, filtration fraction and
intraluminal oncotic pressure were highest in the absence of
predilution, and therefore the relative increase in solute clear-
ance greatest.
Enhancement of clearance with predilution for solutes other
than urea is controversial. Kaplan and Golper [31] have sug-
gested that movement of urea out of RBC's may be responsible
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Fig. 7. Filtrate fr,natio;, rate, Q, a,s a fund ion of colu,un /iei'ht for
the V—V and S—V access configurations. Solid lines refer to model
simulations, while dashed lines are best fit regressions to data points.
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(34) " Measured result is significantly greater than postdilution or no
dilution (P < 0.05)
for improved clearance of that solute with predilution. Other
solutes may not be distributed within the intraerythrocytic
volume (equation 17, t = 0) or might fail to redistribute across
the RBC membrane due to equilibration time that exceeds
hemofilter transit time. Data is available which suggests that,
for many other solutes of interest such as inulin, creatinine, and
uric acid, such a failure to equilibrate will be the case [14].
Motivated by these issues, we considered the behavior of a
solute which is unbound, passes the hemofilter membrane with
a sieving coefficient of one, and either does not distribute within
the RBC (1 = 0), or distributes, but does not equilibrate with
plasma during hemofilter transit. Either of these limiting cases
is identical in so far as model predictions of blood flow, filtrate
formation, and solute clearance is concerned. Since the differ-
ence between intraerythrocytic mass flow of such a solute
upstream and downstream of the filter would be zero, equation
16 takes the form,
d S
— {Q(l — =
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Fig. 8. Filtrate formation rate (so/id lines) or urea clearance (broken
lines) as predilution rate, Qj, is increased using various access
configurations. Model inputs employ the base case parameter set.
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Fig. 9. Broken lines show the clearance of a solute that distributes
within the ers'throcyte and equilibrates with plasma during hemofilter
transit. Solid lines show the clearance if the solute either does not
distribute within the red blood cell, or does distribute but undergoes no
equilibration with the plasma during hemofilter transit. The clearances
are shown for the V-S and V-V access configuration, base case
parameter set, as predilution rate, QdI, is varied.
equation 29 becomes,
=
(I — :1(1 — J-I;t (36)(1 — "P C0){(l — H)Qb + QdI}
and, Cl is computed from,
C = {C0(1 — 'CO)QO — (l — 'P C1)Q1} (37)
Using the base case parameter set with 1 = I (broken curve),
or 0 (solid curve), and f = I the result shown in Figure 9 is
predicted. For solutes that do not distribute into the erythro-
cyte, or undergo no equilibration across the RBC membrane,
the model suggests, depending upon the access configuration
employed, that predilution may not enhance clearance or might
enhance it to a lesser degree than for urea. Thus, the detrimen-
tal effect of reduced plasma concentration may exceed the
beneficial effect of a higher filtration rate. It is also of interest(35)
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Fig. 10. Broken lines show the clearance of a solute when the predilu
lion rate, Qd,, is 10 mI/mm, and solid lines when QdI is zero. The
clearances are shown for a solute, the hemofilter membrane diffusive
permeability for which is infinity (Pe = 0), (upper curves), or zero (Pe =), (lower curves). Pe is the Peclet number of the solute (equation 19).
that the simulation for the V-S configuration in Figure 9
suggests that an optimum value for the predilution rate may
exist which, again, will depend upon the characteristics of the
solute, patient, and circuit.
Another question with regard to predilution concerns the
behavior of solutes of higher molecular weight which do not
pass the hemofilter membrane freely (O < 1). Such solutes
would be concentrated during hemofilter transit so that diffusive
transport would contribute to clearance. In general, high mo-
lecular weight solutes would not be expected to equilibrate
across the RBC membrane and therefore conforms to the case
described above (t = 0). Figure 10 shows the predictions for the
base case parameter set, f 0, and e either equal to zero (P
= infinity) or infinity (P = 0), as f is varied from zero to one
and Q is either zero (solid curve) or 10 mI/mm (broken curve)
with the V-S configuration. Even with this access arrangement,
where predilution is expected to be most beneficial (Figure 8),
improvement in solute clearance is predicted to be minimal.
Discussion
We have described the use of an apparatus for in vitro
perfusion of the CAVH circuit. By systematic variation of
perfusion pressure, access configuration, and ultrafiltrate col-
umn height, the response of the system with regard to blood
flow rate, filtration pressure, and filtrate output has been
investigated. In addition, the agreement of experiment with the
predictions of a mathematical model has been described. The
system was perfused with packed RBC's resuspended in an
albumin solution. Plasma was deficient in clotting factors,
globulins, fibrinogen and platelets. Since wall shear rates sub-
stantially exceeded that below which the yield stress of normal
blood would dominate, we anticipate that rheological behavior
was similar [9]. Nonpulsatile flow is a limitation of the tech-
nique. Others have shown that viscous energy losses were
similar when capillary tubes were perfused in steady or pulsatile
fashion [32] and the rates of filtrate production and blood flow
rate observed with this system were similar to the clinical
observations of others [1—4].
An important finding concerns the behavior of individual
CAVE components. In a manner consistent with the applica-
tion of Poiseuille's equation to predict their behavior, flow
through individual CAVH circuit components responded linearly
to increases in perfusion pressure. Measurements of resistances
were sufficiently close to calculated values that modeling of
other system geometries can be performed with such estimates.
Reynold's numbers were less than 1000 for all flows and regions
of the circuit, which is essential for the application of laminar
flow equations. Review of resistances show that only for the
Vygon® catheter is this insignificant compared to other compo-
nents. It is clear that optimum flow can be established by the
use of the 3 mm internal diameter catheter and shortening of
blood lines, although adequate filtrate output can be achieved
with smaller bore catheters. Also clear is that shortening of
blood lines will have little effect if a poor access is used on
either end of the circuit.
In addition to the magnitude of the access resistance, its
location is of major consequence. We have demonstrated the
marked reduction in filtrate output that accompanies a poor
arterial access. To a degree, increasing the height of the
ultrafiltrate column can overcome unfavorable Starling forces,
but the low blood flow rate will ultimately limit filtrate forma-
tion rates, and the higher filtration fraction might encourage
hemofilter thrombosis. It has been stated that CAVH systems
operating with less than 20% filtration fraction have inadequate
transmembrane pressure [2, 3]. While this may be true when
blood flow rates are low, this comment seems otherwise unwar-
ranted. With large bore (3 mm internal diameter) catheters in
both access positions, and an arteriovenous pressure gradient
of 70 mm Hg, blood flow rate of 100 mI/mm can be achieved.
When hematocrit is 30%, a filtration fraction of 15% yields 10
mi/mm of filtrate, generally sufficient to control volume over-
load and replace renal function. Perhaps an optimally function-
ing system is one that provides the necessary filtrate output
with the lowest possible filtration fraction. It seems likely that
filter life would be prolonged under such conditions.
A marked decline in filter permeability has been observed
during use. This decrease was due to interaction of protein with
the membrane surface. The time span over which this occurred
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was one to two hours, after which there was stabilization of
filter properties.
In addition to systematically demonstrating principles of
operation, this study provided an opportunity to evaluate a
mathematical model. When the resistance and permeability of
the individual filters were determined, agreement of measure-
ments with predictions of blood flow rates and pressures
throughout the circuit was reasonable. Derivation of that model
employed Poiseuille's equation in differential form in order to
calculate spatial variation of pressure along the filter. In turn,
derivation of Poiseuille's law from the Navier-Stokes equations
requires the assumption of an invariant viscosity, making this a
questionable approach [33], Our success in predicting pressure
distribution within the circuit lends support to the applicability
of this method for conditions of operation in CAVH.
A shortcoming of the model is its inability to accurately
predict the rate of filtrate formation when a system operates
with low blood flow rate and high transmembrane volume flux.
Solutes rejected at the membrane surface must diffuse back
toward the center of the fibers at the same rate they reach this
surface by convection. Proteins, due to their low diffusivity,
may do this only upon establishment of a substantial radial
concentration gradient. Under these conditions, calculation of
membrane fluxes on the basis of Starling forces and bulk protein
concentration will give incorrect results. The ratio of convec-
tive to diffusive transport of protein is embodied in the Peclet
number for protein, P1, [34]. The radial 1ep is calculated as
(Vr)/D where V is radial velocity of the fluid, r the radius of the
tube and D the diffusivity of protein (about 7 x l0- cm2/sec for
albumin). Within the hollow fibers of the D-20, e1, is about one
when filtrate is formed at 10 mI/mm, suggesting that transmem-
brane volume flux may be significant in determining the radial
distribution of proteins. In view of this, it may seem somewhat
surprising that agreement with model predictions appears to be
good. Partial explanation for this involves the presence of
RBC's. In an analogous model involving heat transfer, particles
in suspension have been shown to enhance transport from the
walls of a cylinder to a test solution in laminar flow [35].Colton
et al, perfusing hollow fibers with blood of hematocrit 17% and
protein concentration 2.7 g/dl, show an apparent hydraulic
permeability close to that of normal saline when the ratio of wall
shear rate (equal to 8 V/d where d is fiber diameter, and V is
average fluid velocity) to fiber length was 53 l/(cm sec) and
transmembrane pressure less than 150 mm Hg [Fig. I of
reference 111. In this study, the latter quantity varied from
about 12 to 41 l/(cm sec). Given that hematocrits in this study
are substantially higher, the agreement with Starling's equation
that we find is consistent. Lysaght et al have also concluded
that boundary layer effects in CAVH appear to be minimal [13].
Over many conditions of interest, our model adequately
predicts system behavior. Exceptions to this would be an
access arrangement which produced a high transmembrane
volume flux in a poorly flowing system, or where large negative
pressures were used to maximize volume removal as in the case
of applying wall suction [361. Questions concerned with the
design and optimization of CAVH can otherwise be addressed
with a digital computer in addition to pursuit of in vivo or in
vitro testing.
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